Crescent Capital BDC has shown strong price performance, solid financial growth, and high credit quality, making it a fundamentally sound buy despite a challenging economic backdrop. The BDC out-earne...

Risk is the probability of a negative event in the future. An abstract concept that is not measurable; otherwise it would not be risk. Ascertaining value is the first step in controlling risk, that is...

NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns a rating of BBB- to Crescent Capital BDC, Inc.'s (“CCAP” or “the company”) $115 million senior unsecured notes due in 2028 and 2030. The n...

CCAP is a defensive BDC with a 90% concentration on first-lien debt, ensuring high repayment priority during potential litigation processes. The portfolio focuses on non-cyclical businesses (85%), pro...

Item 1.01. Entry into a Material Definitive Agreement On December 3, 2024, Crescent Capital BDC, Inc. (the "Company") and certain subsidiaries of the Company entered into an Amended and Restated Senio...

Inflation makes Crescent Capital and Crown Castle compelling income-generating investments with yields of 9% and 6%, respectively. Crescent Capital offers a diversified portfolio with a strong 1st lie...

Closed-end funds are special income vehicles, with many positive aspects and just as many weaknesses that take time to be properly understood and evaluated. I discovered their existence about ten year...

The recent rally in small-cap stocks indicates strong market confidence toward 2025, also making Crescent Capital BDC a compelling income investment. CCAP should benefit from a pro-small business tax ...

Crescent Capital's strong dividend coverage and NAV growth indicate a resilient portfolio. The current dividend yield is 9.7% and is well supported by earnings. The portfolio, valued at $1.6B, is conc...

Crescent Capital BDC, Inc. (NASDAQ:CCAP ) Q3 2024 Earnings Conference Call November 12, 2024 12:00 PM ET Company Participants Dan McMahon - Head, Investor Relations Jason Breaux - Chief Executive Offi...

Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.59 per share a year ago.

Crescent Capital BDC offers a compelling 9% regular yield and 11% total yield, supported by a diversified portfolio and strong earnings coverage. CCAP's portfolio quality is robust, with a low non-acc...

My portfolio includes CEFs, ETFs, a few BDCs and an ETN, for whose selection I have developed over the years a criterion based mainly on NAV performance. In this article, however, I decided to focus o...